Mobile Telesystems (MBT) 9.95 $MBT Mobile Telesystems

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Mobile Telesystems (MBT) 9.95 $MBT

Mobile Telesystems Has Returned 18.3% Since SmarTrend Recommendation (MBT)
Comtex SmarTrend(R) - Fri Mar 20, 10:11AM CDT
SmarTrend identified an Uptrend for Mobile Telesystems (NYSE:MBT) on December 18th, 2014 at $8.34. In approximately 3 months, Mobile Telesystems has returned 18.30% as of today's recent price of $9.86.
MBT: 9.95 (+0.28)

Mobile TeleSystems' (MBT) CEO Andrei Dubovskov on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Mar 17, 4:24PM CDT

MBT: 9.95 (+0.28)

Ruble woes hammer profits at Russian leader Mobile TeleSystems
Seeking Alpha - at Seeking Alpha - Tue Mar 17, 8:00AM CDT

MBT: 9.95 (+0.28)

Mobile TeleSystems beats on revenue
Seeking Alpha - at Seeking Alpha - Tue Mar 17, 7:17AM CDT

MBT: 9.95 (+0.28)

Mobile TeleSystems Announces Financial Results for the Fourth Quarter and Full Year Ended December 31, 2014
PR Newswire - Tue Mar 17, 7:00AM CDT
Mobile TeleSystems OJSC ("MTS" - NYSE: MBT), the leading telecommunications provider in Russia and the CIS, today announces its unaudited US GAAP financial results for the three months and full year ended December 31, 2014.
MBT: 9.95 (+0.28)

Mobile Telesystems Shares Up 9.6% Since SmarTrend's Buy Recommendation (MBT)
Comtex SmarTrend(R) - Fri Mar 13, 9:42AM CDT
SmarTrend identified an Uptrend for Mobile Telesystems (NYSE:MBT) on December 18th, 2014 at $8.34. In approximately 3 months, Mobile Telesystems has returned 9.60% as of today's recent price of $9.13.
MBT: 9.95 (+0.28)

Russian telecoms decline as ruble gives up recent gains
Seeking Alpha - at Seeking Alpha - Tue Mar 10, 8:56AM CDT

VIP: 5.34 (+0.08), TKC: 12.50 (+0.18), MBT: 9.95 (+0.28)

VimpelCom posts Q4, 2014 losses amid tumbling currencies
Seeking Alpha - at Seeking Alpha - Wed Feb 25, 7:26AM CST

VIP: 5.34 (+0.08), MBT: 9.95 (+0.28)

VimpelCom, MTS, Turkcell win Ukraine 3G rights
Seeking Alpha - at Seeking Alpha - Tue Feb 24, 9:50AM CST

VIP: 5.34 (+0.08), TKC: 12.50 (+0.18), MBT: 9.95 (+0.28)

Stocks in Wait-and-See Mode Ahead of Yellen's Congressional Address
at The Street - Mon Feb 23, 3:08PM CST
Stocks didn't make big moves on Monday with investors preferring to wait on the sidelines ahead of key U.S. data out later in the week.
DHI: 27.33 (+0.38), VIP: 5.34 (+0.08), MMM: 166.49 (+0.83), TSLA: 198.08 (+2.43), VRX: 204.26 (+2.17), XOM: 84.54 (+0.13), MBT: 9.95 (+0.28), SLB: 82.37 (+1.36), PPO: 59.18 (+0.02), XHB: 36.43 (+0.57), FOXA: 35.30 (+0.84), KBH: 15.26 (+1.18), AAPL: 125.90 (-1.60), XLE: 76.91 (+0.60), QIWI: 21.34 (+0.70), HAL: 42.82 (+1.27), SLXP: 172.80 (+0.26), HSBC: 43.56 (+0.99), DISCA: 32.45 (+0.63), BA: 154.50 (+0.39), XLV: 74.90 (+0.33), PHM: 21.77 (+0.40), CVX: 107.03 (+2.28), TOL: 38.70 (+0.55), YNDX: 14.63 (+0.17)

Stocks Slide as Energy Weighs; Tesla Pulls Nasdaq Lower
at The Street - Mon Feb 23, 2:22PM CST
Stocks are inching lower on Monday with a selloff among energy and homebuilder stocks offsetting gains in health care.
DHI: 27.33 (+0.38), VIP: 5.34 (+0.08), MMM: 166.49 (+0.83), VRX: 204.26 (+2.17), XOM: 84.54 (+0.13), MBT: 9.95 (+0.28), SLB: 82.37 (+1.36), PPO: 59.18 (+0.02), XHB: 36.43 (+0.57), FOXA: 35.30 (+0.84), KBH: 15.26 (+1.18), AAPL: 125.90 (-1.60), XLE: 76.91 (+0.60), QIWI: 21.34 (+0.70), HAL: 42.82 (+1.27), SLXP: 172.80 (+0.26), HSBC: 43.56 (+0.99), DISCA: 32.45 (+0.63), BA: 154.50 (+0.39), PHM: 21.77 (+0.40), CVX: 107.03 (+2.28), TOL: 38.70 (+0.55), YNDX: 14.63 (+0.17)

YNDX, QIWI, VIP, MBT tumble after Moody's downgrade, sanctions threat
Seeking Alpha - at Seeking Alpha - Mon Feb 23, 10:09AM CST

VIP: 5.34 (+0.08), QIWI: 21.34 (+0.70), MBT: 9.95 (+0.28), YNDX: 14.63 (+0.17)

Goldman lifts outlook on Turkcell
Seeking Alpha - at Seeking Alpha - Tue Feb 17, 5:49PM CST

VIP: 5.34 (+0.08), TKC: 12.50 (+0.18), MBT: 9.95 (+0.28)

S&P 500 Closes at Record High Amid Mixed Messages on Greece
at The Street - Tue Feb 17, 3:14PM CST
It was a wishy-washy type of day on Wall Street as mixed messages on Greece confused market direction.
VIP: 5.34 (+0.08), GT: 25.66 (+0.48), RUSL: 21.19 (+1.81), SRPT: 13.16 (-0.76), M: 65.98 (+0.91), MBT: 9.95 (+0.28), AAPL: 125.90 (-1.60), YNDX: 14.63 (+0.17), HOT: 84.39 (+0.89)

Stock Markets Run in Place After Mixed Reports on Greece
at The Street - Tue Feb 17, 2:23PM CST
U.S. stocks turn higher by early afternoon Tuesday, boosted by whispers Greece might concede to a six-month extension to its current bailout package.
VIP: 5.34 (+0.08), GT: 25.66 (+0.48), RIG: 14.99 (+0.83), RUSL: 21.19 (+1.81), SRPT: 13.16 (-0.76), MBT: 9.95 (+0.28), AAPL: 125.90 (-1.60), YNDX: 14.63 (+0.17), HOT: 84.39 (+0.89)

Mobile Telesystems Has Returned 21.5% Since SmarTrend Recommendation (MBT)
Comtex SmarTrend(R) - Tue Feb 17, 9:40AM CST
SmarTrend identified an Uptrend for Mobile Telesystems (NYSE:MBT) on December 18th, 2014 at $8.34. In approximately 2 months, Mobile Telesystems has returned 21.54% as of today's recent price of $10.13.
MBT: 9.95 (+0.28)

VimpelCom, Hutchison reportedly closer to merging Italy operations
Seeking Alpha - at Seeking Alpha - Tue Feb 17, 9:02AM CST

VIP: 5.34 (+0.08), TI: 11.74 (+0.29), TKC: 12.50 (+0.18), MBT: 9.95 (+0.28)

Premarket Gainers / Losers as of 9:10 am
Seeking Alpha - at Seeking Alpha - Fri Feb 13, 8:15AM CST

CYTK: 7.76 (-0.19), HK: 1.60 (+0.02), CYBR: 48.69 (-1.72), FXEN: 1.32 (-0.07), NBG: 1.34 (+0.14), MBT: 9.95 (+0.28), SDRL: 9.83 (+0.46), MTSN: 3.99 (-0.01), BLDP: 2.06 (-0.01), GDP: 3.12 (+0.09), REXX: 3.85 (-0.05), DNR: 7.46 (-0.04), ZNGA: 2.70 (+0.05), KING: 15.10 (+0.42), SD: 1.64 (+0.07), MX: 5.51 (+0.01), KN: 19.99 (-1.02), GENE: 3.88 (-0.09), VDSI: 23.13 (-1.57), IDRA: 4.18 (-0.25), SFY: 2.12 (-0.07), ARIA: 8.69 (-0.28), FSL: 43.39 (+0.82), PRAN: 1.15 (-0.08), OAS: 13.80 (-0.16)

YNDX, QIWI, MBT rally following Ukraine cease-fire
Seeking Alpha - at Seeking Alpha - Thu Feb 12, 8:48AM CST

QIWI: 21.34 (+0.70), MBT: 9.95 (+0.28), YNDX: 14.63 (+0.17)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 37

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 24

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 35

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 26

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 34

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 35

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading

Top 5 Most Recently Viewed Articles

TSA PreCheck Study Reveals Time Savings and Travel Insights

Updated Category News Views 379

Understanding TSA PreCheck's Impact on Travelers The latest survey reveals some interesting insights about TSA PreCheck, especially concerning the time savings that members experience at security checkpoints. Conducted by Upgraded Points, this enlightening study assessed the experience of over 1,500 travelers to evaluate the true advantages of holding a TSA PreCheck...

Continue Reading
Intermap Technologies Enhances Geospatial Solutions with New Offering

Updated Category News Views 217

Intermap Technologies Announces New Prospectus Supplement DENVER – Intermap Technologies Corporation (TSX: IMP; OTCQB: ITMSF), a recognized leader in 3D geospatial products and intelligence solutions, has filed a prospectus supplement in the context of a strategically planned public offering. This initiative signifies a promising step forward, with the company aiming to...

Continue Reading
Urgent Investor Notice: Humacyte Legal Claims Investigation

Updated Category News Views 94

Critical Deadline for Humacyte Investors Approaches As time runs short, investors in Humacyte, Inc. (NASDAQ: HUMA) should pay attention. Faruqi & Faruqi, LLP, a prominent national securities law firm, is actively investigating claims on behalf of investors who have suffered losses exceeding $75,000 due to potential violations in federal securities laws. Understanding Your...

Continue Reading
Empowering Women in Banking: Natalie Bartholomew at Alkami Co:lab

Updated Category News Views 226

Empowering Women in Banking: Natalie Bartholomew at Alkami Co:lab Natalie Bartholomew, a highly recognized advocate for women in financial services, will be the featured speaker for the Women in Banking session at Alkami Co:lab 2026. Her expertise and passion are expected to inspire attendees and foster discussions around women's roles in the financial sector. Alkami...

Continue Reading
Investors Anticipate Strong Earnings from OPAL Fuels Soon

Updated Category News Views 161

OPAL Fuels Earnings Report Insights OPAL Fuels OPAL is preparing to release its quarterly earnings report soon, and investors are keenly interested in the results. As the anticipated date for this report approaches, it is essential for investors to stay informed and understand what the expectations are. Projected Earnings Overview Analysts project that OPAL Fuels will...

Continue Reading